Last reviewed 2026-04-22 · How we verify

Standard interval dosing

Standard interval dosing is a dosing schedule approach rather than a drug itself, referring to the administration of medications at regular, fixed time intervals.

At a glance

Mechanism of action

Standard interval dosing is a pharmaceutical administration strategy where a drug is given at consistent, predetermined time intervals (e.g., every 8 hours, once daily) rather than as-needed or adaptive dosing. This approach maintains relatively steady-state drug concentrations and is the most common dosing paradigm in clinical practice. It is not a specific drug but rather a dosing methodology that can be applied to any pharmaceutical agent.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss (PHASE2)
• A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia (PHASE3)
• Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection (PHASE2)
• A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B (PHASE3)
• Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma (PHASE2)
• SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer
• Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya (PHASE4)
• PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders) (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.